Operating Margin in % of ABVC BIOPHARMA, INC. from 2010 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Abvc Biopharma, Inc. quarterly/annual Operating Margin history and change rate from 2010 to Q4 2024.
  • Abvc Biopharma, Inc. Operating Margin for the quarter ending 31 Dec 2024 was -923 %, a 79.2% increase year-over-year.
  • Abvc Biopharma, Inc. annual Operating Margin for 2024 was -923 %, a 79.2% increase from 2023.
  • Abvc Biopharma, Inc. annual Operating Margin for 2023 was -4.44K %, a 185% decline from 2022.
  • Abvc Biopharma, Inc. annual Operating Margin for 2022 was -1.56K %, a 52.6% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2024 -923 +3.52K +79.2% 01 Oct 2024 31 Dec 2024
Q3 2024 -885 +385 +30.3% 01 Jul 2024 30 Sep 2024
Q2 2024 -4.67K -3.24K -226% 01 Apr 2024 30 Jun 2024
Q1 2024 -30.4K -29.3K -2914% 01 Jan 2024 31 Mar 2024
Q4 2023 -4.44K -2.88K -185% 01 Oct 2023 31 Dec 2023
Q3 2023 -1.27K +4.1K +76.4% 01 Jul 2023 30 Sep 2023
Q2 2023 -1.43K +2.74K +65.7% 01 Apr 2023 30 Jun 2023
Q1 2023 -1.01K +13.1K +92.9% 01 Jan 2023 31 Mar 2023
Q4 2022 -1.56K +1.73K +52.6% 01 Oct 2022 31 Dec 2022
Q3 2022 -5.37K -3.15K -142% 01 Jul 2022 30 Sep 2022
Q2 2022 -4.17K -2.18K -109% 01 Apr 2022 30 Jun 2022
Q1 2022 -14.1K -12.8K -995% 01 Jan 2022 31 Mar 2022
Q4 2021 -3.29K -1.53K -86.8% 01 Oct 2021 31 Dec 2021
Q3 2021 -2.22K -1.3K -142% 01 Jul 2021 30 Sep 2021
Q2 2021 -2K -1.23K -161% 01 Apr 2021 30 Jun 2021
Q1 2021 -1.29K -600 -87.5% 01 Jan 2021 31 Mar 2021
Q4 2020 -1.76K -1.27K -257% 01 Oct 2020 31 Dec 2020
Q3 2020 -918 01 Jul 2020 30 Sep 2020
Q2 2020 -764 01 Apr 2020 30 Jun 2020
Q1 2020 -686 01 Jan 2020 31 Mar 2020
Q4 2019 -493 01 Oct 2019 31 Dec 2019
Q3 2015 -6.79K 21 Jul 2015 30 Sep 2015
Q4 2013 -5.23K* +2.45K 01 Oct 2013 31 Dec 2013
Q3 2013 -2.28K +17.7K +88.6% 01 Jul 2013 30 Sep 2013
Q2 2013 -3.66K +21.8K +85.6% 01 Apr 2013 30 Jun 2013
Q1 2013 -6.57K +28.1K +81.1% 01 Jan 2013 31 Mar 2013
Q4 2012 -7.68K +63.8K +89.2% 01 Oct 2012 31 Dec 2012
Q3 2012 -20K +39.2K +66.2% 01 Jul 2012 30 Sep 2012
Q2 2012 -25.4K 01 Apr 2012 30 Jun 2012
Q1 2012 -34.7K 01 Jan 2012 31 Mar 2012
Q4 2011 -71.5K 01 Oct 2011 31 Dec 2011
Q3 2011 -59.2K 01 Jul 2011 30 Sep 2011

ABVC BIOPHARMA, INC. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -923 +3.52K +79.2% 01 Jan 2024 31 Dec 2024
2023 -4.44K -2.88K -185% 01 Jan 2023 31 Dec 2023
2022 -1.56K +1.73K +52.6% 01 Jan 2022 31 Dec 2022
2021 -3.29K -1.53K -86.8% 01 Jan 2021 31 Dec 2021
2020 -1.76K -1.27K -257% 01 Jan 2020 31 Dec 2020
2019 -493 +39.5K +98.8% 01 Jan 2019 31 Dec 2019
2018 -40K 01 Jan 2018 31 Dec 2018
2013 -2.28K +17.7K +88.6% 01 Oct 2012 30 Sep 2013
2012 -20K +39.2K +66.2% 01 Oct 2011 30 Sep 2012
2011 -59.2K -46.5K -365% 01 Oct 2010 30 Sep 2011
2010 -12.7K 01 Oct 2009 30 Sep 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.